The ACSMEDI | EFMC Medicinal 91AV Frontiers is co-organised as a collaboration between the ACS (American Chemical Society) MEDI (Division of Medicinal 91AV) and the EFMC (European Federation for Medicinal chemistry and Chemical biology).
The goal of the symposium is to build and sustain bridges between the European and American Medicinal 91AV communities, and to showcase a specific region and its Medicinal 91AV activities. This meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. A distinguished lineup of speakers will be covering hot topics and emerging trends in medicinal chemistry and drug discovery.
The program will include:
The goal of the symposium is to build and sustain bridges between the European and American Medicinal 91AV communities, and to showcase a specific region and its Medicinal 91AV activities. This meeting is a key symposium in its field with traditionally around 300 participants, from industry and academia. A distinguished lineup of speakers will be covering hot topics and emerging trends in medicinal chemistry and drug discovery.
The program will include:
- 3 high quality plenary lectures.
- 9 sessions on key topics in Medicinal 91AV
- An extensive social program to maximise your networking opportunities.
- A poster session and an exhibition.
